| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ad5c8da3d75c778c085502f5e53daee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85483ac98517c2c3d67bb829aa5d816f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9b9869ed748a1a8a6b69bdf557e02c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c36c05cad069a15711ea8f94d0c75092 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 |
| filingDate |
2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f83532122874c1b0f7a249bc53498a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504fe6522e0d5ed785249fb06a4a2afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06b49cac81dcda4922c46d9cf45e2103 |
| publicationDate |
2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9968678-B2 |
| titleOfInvention |
Liquid pharmaceutical composition for the delivery of active ingredients |
| abstract |
The invention provides novel pharmaceutical compositions based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble and/or hydrolytically sensitive drug substances. The compositions are designed as suspensions and have superior physical properties which make them highly useful as pharmaceutical delivery systems. The compositions may be administered topically into the eye, or injected via the subcutaneous or intramuscular route. The invention further provides kits comprising such compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11576893-B2 |
| priorityDate |
2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |